Evolent Health, Inc. (EVH)
After hours:
| Previous Close | 29.26 |
| Open | 28.97 |
| Bid | 0.00 x 1300 |
| Ask | 0.00 x 900 |
| Day's Range | 28.12 - 28.97 |
| 52 Week Range | 23.33 - 36.70 |
| Volume | |
| Avg. Volume | 917,624 |
| Market Cap | 3.225B |
| Beta (5Y Monthly) | 1.54 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make healthcare simpler and more affordable, today announced it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after market close, with a conference call to follow at 5 p.m. ET.
- PR Newswire
Evolent Announces Fourth Quarter and Full Year 2023 Results
Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months and year ended December 31, 2023.
- PR Newswire
Evolent Adds Russell Glass, Headspace CEO, to Board of Directors
Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today appointed Russell Glass to its Board of Directors. Glass has almost 25 years of experience as a successful technology and health care executive who currently serves as Chief Executive Officer of Headspace, a pioneering company focused on digitally enabled mental health support for employers, hea
